QUALCOMM INC/DE, 10-Q filed on 5/1/2024
Quarterly Report
v3.24.1.u1
Cover Page - shares
shares in Millions
6 Months Ended
Mar. 24, 2024
Apr. 29, 2024
Cover [Abstract]    
Entity Registrant Name QUALCOMM INC/DE  
Entity Central Index Key 0000804328  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Current Fiscal Year End Date --09-29  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 24, 2024  
Document Transition Report false  
Entity File Number 0-19528  
Entity Registrant State of Incorporation DE  
Entity Employer ID 95-3685934  
Entity Address 5775 Morehouse Dr.  
Entity City San Diego  
Entity State CA  
Entity Zip Code 92121-1714  
City Area Code (858)  
Entity Phone Number 587-1121  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol QCOM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,116
v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Millions, $ in Millions
Mar. 24, 2024
Sep. 24, 2023
Current assets:    
Cash and cash equivalents $ 9,219 $ 8,450
Marketable securities 4,632 2,874
Accounts receivable, net 3,054 3,183
Inventories 6,087 6,422
Held for sale assets 0 341
Other current assets 1,240 1,194
Total current assets 24,232 22,464
Deferred tax assets 3,978 3,310
Property, plant and equipment, net 4,724 5,042
Goodwill 10,760 10,642
Other intangible assets, net 1,331 1,408
Held for sale assets 0 88
Other assets 8,142 8,086
Total assets 53,167 51,040
Current liabilities:    
Trade accounts payable 2,314 1,912
Payroll and other benefits related liabilities 1,253 1,685
Unearned revenues 253 293
Short-term debt 914 914
Held for sale liabilities 0 333
Other current liabilities 4,409 4,491
Total current liabilities 9,143 9,628
Unearned revenues 135 99
Income taxes payable 526 1,080
Long-term debt 14,543 14,484
Held for sale liabilities 0 38
Other liabilities 4,351 4,130
Total liabilities 28,698 29,459
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding $ 0 $ 0
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 8 8
Preferred stock, shares outstanding 0 0
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,118 and 1,114 shares issued and outstanding, respectively $ 66 $ 490
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 6,000 6,000
Common stock, shares, issued 1,118 1,114
Common stock, shares, outstanding 1,118 1,114
Retained earnings $ 23,965 $ 20,733
Accumulated other comprehensive income 438 358
Total stockholders’ equity 24,469 21,581
Total liabilities and stockholders’ equity $ 53,167 $ 51,040
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Revenues:        
Equipment and services $ 7,950 $ 7,846 $ 16,266 $ 15,630
Licensing 1,439 1,429 3,059 3,108
Total revenues 9,389 9,275 19,325 18,738
Costs and expenses:        
Cost of revenues 4,106 4,153 8,418 8,197
Research and development 2,236 2,210 4,332 4,461
Selling, general and administrative 707 614 1,335 1,238
Other (Note 2) 0 208 (28) 288
Total costs and expenses 7,049 7,185 14,057 14,184
Operating income 2,340 2,090 5,268 4,554
Interest expense (172) (179) (350) (348)
Investment and other income (expense), net 330 (16) 542 60
Income from continuing operations before income taxes 2,498 1,895 5,460 4,266
Income tax expense (223) (193) (373) (291)
Income from continuing operations 2,275 1,702 5,087 3,975
Discontinued operations, net of income taxes 51 2 6 (36)
Net income $ 2,326 $ 1,704 $ 5,093 $ 3,939
Basic earnings per share, Continuing operations $ 2.03 $ 1.53 $ 4.55 $ 3.55
Basic loss per share, Discontinued operations 0.05 0 0.01 (0.03)
Basic earnings per share 2.08 1.53 4.56 3.52
Diluted earnings per share, Continuing operations 2.02 1.52 4.50 3.52
Diluted loss per share, Discontinued operations 0.04 0 0.01 (0.03)
Diluted earnings per share $ 2.06 $ 1.52 $ 4.51 $ 3.49
Shares used in per share calculations:        
Basic 1,117 1,116 1,116 1,119
Diluted 1,130 1,123 1,129 1,127
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Statement of Comprehensive Income [Abstract]        
Net income $ 2,326 $ 1,704 $ 5,093 $ 3,939
Other comprehensive income, net of income taxes:        
Foreign currency translation (losses) gains (62) 72 21 234
Net unrealized gains on available-for-sale debt securities 6 21 38 36
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax (13) 16 4 134
Other (losses) gains (1) 6 0 6
Other reclassifications included in net income 15 10 17 30
Total other comprehensive (loss) income (55) 125 80 440
Comprehensive income $ 2,271 $ 1,829 $ 5,173 $ 4,379
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Operating Activities:    
Net income from continuing operations $ 5,087 $ 3,975
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 848 868
Income tax provision less than income tax payments (1,764) (631)
Share-based compensation expense 1,307 1,262
Net gains on marketable securities and other investments (273) (45)
Impairment losses on other investments 62 101
Other items, net (30) 16
Changes in assets and liabilities:    
Accounts receivable, net 92 1,964
Inventories 328 (396)
Other assets 221 615
Trade accounts payable 420 (2,358)
Payroll, benefits and other liabilities 286 (672)
Unearned revenues 10 (86)
Net cash used by operating activities from discontinued operations (91) (61)
Net cash provided by operating activities 6,503 4,552
Investing Activities:    
Capital expenditures (398) (851)
Purchases of debt and equity marketable securities (2,842) (22)
Proceeds from sales and maturities of debt and equity marketable securities 1,178 491
Acquisitions and other investments, net of cash acquired (165) (61)
Proceeds from sales of property, plant and equipment 8 121
Proceeds from other investments 62 11
Other items, net (38) (46)
Net cash used by investing activities (2,195) (357)
Financing Activities:    
Proceeds from short-term debt 799 4,668
Repayment of short-term debt (799) (4,668)
Proceeds from long-term debt 0 1,880
Repayment of long-term debt 0 1,446
Proceeds from issuance of common stock 195 232
Repurchases and retirements of common stock (1,515) (2,173)
Dividends paid (1,790) (1,676)
Payments of tax withholdings related to vesting of share-based awards (515) (332)
Other items, net 4 (43)
Net cash used by financing activities (3,621) (3,558)
Effect of exchange rate changes on cash and cash equivalents 5 46
Net increase in total cash and cash equivalents 692 683
Total cash and cash equivalents at beginning of period (including $77 and $326 classified as held for sale at September 24, 2023 and September 25, 2022, respectively) 8,527 3,099
Total cash and cash equivalents at end of period (including $294 classified as held for sale at March 26, 2023) 9,219 3,782
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, Beginning of Period $ 77 326
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, End of Period   $ 294
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock and paid-in capital
Retained earnings
Accumulated other comprehensive income
Balance at beginning of period at Sep. 25, 2022 $ 18,013 $ 195 $ 17,840 $ (22)
Common stock issued under employee benefit plans   232    
Repurchases and retirements of common stock   (1,418) (755)  
Share-based compensation   1,323    
Tax withholdings related to vesting of share-based payments   (332)    
Common stock issued in acquisition   0    
Net income     3,939  
Dividends     (1,744)  
Other comprehensive (loss) income       440
Balance at end of period at Mar. 26, 2023 $ 19,698 0 19,280 418
Dividends per share announced $ 1.50      
Balance at beginning of period at Dec. 25, 2022 $ 18,810 0 18,517 293
Common stock issued under employee benefit plans   194    
Repurchases and retirements of common stock   (827) (76)  
Share-based compensation   656    
Tax withholdings related to vesting of share-based payments   (23)    
Common stock issued in acquisition   0    
Net income     1,704  
Dividends     (865)  
Other comprehensive (loss) income       125
Balance at end of period at Mar. 26, 2023 $ 19,698 0 19,280 418
Dividends per share announced $ 0.75      
Balance at beginning of period at Sep. 24, 2023 $ 21,581 490 20,733 358
Common stock issued under employee benefit plans   195    
Repurchases and retirements of common stock   (1,504) (11)  
Share-based compensation   1,377    
Tax withholdings related to vesting of share-based payments   (515)    
Common stock issued in acquisition   23    
Net income     5,093  
Dividends     (1,850)  
Other comprehensive (loss) income       80
Balance at end of period at Mar. 24, 2024 $ 24,469 66 23,965 438
Dividends per share announced $ 1.60      
Balance at beginning of period at Dec. 24, 2023 $ 23,058 0 22,565 493
Common stock issued under employee benefit plans   193    
Repurchases and retirements of common stock   (731) 0  
Share-based compensation   748    
Tax withholdings related to vesting of share-based payments   (144)    
Common stock issued in acquisition   0    
Net income     2,326  
Dividends     (926)  
Other comprehensive (loss) income       (55)
Balance at end of period at Mar. 24, 2024 $ 24,469 $ 66 $ 23,965 $ 438
Dividends per share announced $ 0.80      
v3.24.1.u1
Basis of Presentation and Significant Accounting Policies Update
6 Months Ended
Mar. 24, 2024
Basis of Presentation [Abstract]  
Basis of Presentation and Significant Accounting Policies Update Basis of Presentation and Significant Accounting Policies Update
Financial Statement Preparation. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all normal recurring adjustments necessary for a fair statement of the results for the interim periods. These condensed consolidated financial statements are unaudited and should be read in conjunction with our Annual Report on Form 10-K for our fiscal year ended September 24, 2023. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three and six months ended March 24, 2024 and March 26, 2023 included 13 weeks and 26 weeks, respectively.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements.
Segment Reporting Disclosures: In November 2023, the Financial Accounting Standards Board (FASB) issued new requirements to disclose certain incremental segment information on an annual and interim basis, including (among other items) additional disclosure about significant segment expenses. We will adopt the new requirements for our annual periods starting in fiscal 2025 (and interim periods thereafter) on a retrospective basis.
Income Tax Disclosures: In December 2023, the FASB issued new requirements to disclose annually certain additional detailed income tax information related to the effective tax rate reconciliation and income taxes paid, among other items. We will adopt the new requirements starting in fiscal 2026 on a retrospective basis.
v3.24.1.u1
Composition of Certain Financial Statement Items
6 Months Ended
Mar. 24, 2024
Condensed Financial Information Disclosure [Abstract]  
Composition of Certain Financial Statement Items Composition of Certain Financial Statement Items
Inventories (in millions)
March 24,
2024
September 24,
2023
Raw materials$157 $176 
Work-in-process3,670 4,096 
Finished goods2,260 2,150 
$6,087 $6,422 
Other Current Liabilities (in millions)
March 24,
2024
September 24,
2023
Customer incentives and other customer-related liabilities
$2,441 $1,821 
Income taxes payable
1,093 1,717 
Other
875 953 
$4,409 $4,491 
Revenues. We disaggregate our revenues by segment (Note 6), by products and services (as presented on our condensed consolidated statement of operations), and for our QCT (Qualcomm CDMA Technologies) segment, by revenue stream, which is based on the industry and application in which our products are sold (as presented below). In certain cases, the determination of QCT revenues by industry and application requires the use of certain assumptions. Substantially all of QCT’s revenues consist of equipment revenues that are recognized at a point in time, and substantially all of QTL’s (Qualcomm Technology Licensing) revenues represent licensing revenues that are recognized over time and are principally from royalties generated through our licensees’ sales of mobile handsets.
QCT revenue streams were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Handsets (1)$6,180 $6,105 $12,867 $11,860 
Automotive (2)603 447 1,201 903 
IoT (internet of things) (3)
1,243 1,390 2,381 3,071 
Total QCT revenues$8,026 $7,942 $16,449 $15,834 
(1) Includes revenues from products sold for use in mobile handsets.
(2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
(3) Primarily includes products sold for use in the following industries and applications: consumer (including computing, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
Revenues recognized from performance obligations satisfied (or partially satisfied) in previous periods generally include certain QCT sales-based royalty revenues related to system software, certain amounts related to QCT customer incentives and QTL royalty revenues recognized related to devices sold in prior periods (including adjustments to prior period royalty estimates, which includes the impact of the reporting by our licensees of actual royalties due) and were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues recognized from previously satisfied performance obligations$55 $170 $206 $337 
Unearned revenues (which are considered contract liabilities) consist primarily of certain customer contracts for which QCT received fees upfront and QTL license fees for intellectual property with continuing performance obligations. In the six months ended March 24, 2024 and March 26, 2023, we recognized revenues of $227 million and $241 million, respectively, that were recorded as unearned revenues at September 24, 2023 and September 25, 2022, respectively.
Remaining performance obligations, which are primarily included in unearned revenues (as presented on our condensed consolidated balance sheet), represent the aggregate amount of the transaction price of certain customer contracts yet to be recognized as revenues as of the end of the reporting period and exclude revenues related to (a) contracts that have an original expected duration of one year or less and (b) sales-based royalties (i.e., future royalty revenues) pursuant to our license agreements.
Concentrations. A significant portion of our revenues are concentrated with a small number of customers/licensees of our QCT and QTL segments. The comparability of customer/licensee concentrations for the interim periods presented are impacted by the timing of customer/licensee device launches and/or innovation cycles and other seasonal trends, among other fluctuations in demand. Revenues from each customer/licensee that were 10% or greater of total revenues were as follows:
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Customer/licensee (x)
24 %25 %21 %19 %
Customer/licensee (y)
19 27 22 31 
Customer/licensee (z)14 *14 *
*Less than 10%
Other Income, Costs and Expenses. Other income and expenses in the three months ended March 26, 2023 and six months ended March 24, 2024 and March 26, 2023 included certain restructuring amounts (primarily related to accrued severance costs) from cost reduction actions initiated in fiscal 2023.
Investment and Other Income (Expense), Net (in millions)
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Interest and dividend income$160 $59 $312 $114 
Net (losses) gains on marketable securities
(3)20 
Net gains on other investments155 — 159 — 
Net gains on deferred compensation plan assets
62 21 126 47 
Impairment losses on other investments(50)(87)(62)(101)
Other(18)(1)(20)
$330 $(16)$542 $60 
Discontinued Operations. On June 1, 2023, SSW Partners completed the sale of Veoneer’s Active Safety business to Magna International Inc. for net cash proceeds of $1.5 billion. On March 1, 2024, SSW Partners completed the sale of Veoneer’s Restraint Control Systems (RCS) business (collectively with the Active Safety business, the Non-Arriver businesses) to American Industrial Partners Capital Fund VII. Through the date of disposition by SSW Partners, the assets and liabilities of the Non-Arriver businesses have been presented as held for sale on our condensed consolidated balance sheets, and the operating results (including the gain or loss on sale, the amounts of which were not material) and cash flows have been presented as discontinued operations. Cash flows from investing (which includes cash proceeds from the sale of the RCS business) and financing activities from discontinued operations reported for the periods presented were not material.
v3.24.1.u1
Income Taxes
6 Months Ended
Mar. 24, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
We estimate our annual effective income tax rate to be 7% for fiscal 2024, which is lower than the U.S. federal statutory rate, primarily due to (i) a significant portion of our income qualifying for preferential treatment as foreign-derived intangible income (FDII) at a 13% effective tax rate, which includes certain additional benefits from the requirement to capitalize research and development expenditures for federal income tax purposes, (ii) a benefit from our federal research and development tax credit and (iii) excess tax benefits associated with share-based awards. Our effective tax rate of 9% for the second quarter of fiscal 2024 was higher than our estimated annual effective tax rate of 7% primarily due to net discrete tax benefits realized in the first quarter of fiscal 2024. Our effective tax rate of 9% for the second quarter of fiscal 2024 was lower than our effective tax rate of 10% for the second quarter of fiscal 2023, in part reflecting the additional benefit from FDII deductions related to certain changes made in the second half of fiscal 2023 related to income attribution and sourcing of research and development expenditures.
v3.24.1.u1
Capital Stock
6 Months Ended
Mar. 24, 2024
Equity, Attributable to Parent [Abstract]  
Capital Stock Capital Stock
Stock Repurchase Program. On October 12, 2021, we announced a $10.0 billion stock repurchase program. The stock repurchase program has no expiration date. At March 24, 2024, $3.6 billion remained authorized for repurchase under our stock repurchase program.
Shares Outstanding. Shares of common stock outstanding at March 24, 2024 were as follows (in millions):
Balance at September 24, 2023
1,114 
Issued15 
Repurchased(11)
Balance at March 24, 2024
1,118 
Dividends. On March 5, 2024, we announced an increase in our quarterly dividend per share of common stock from $0.80 to $0.85, which is effective for dividends payable after March 21, 2024. On April 17, 2024, we announced a cash dividend of $0.85 per share on our common stock, payable on June 20, 2024 to stockholders of record as of the close of business on May 30, 2024.
Earnings Per Common Share. Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income by the combination of the weighted-average number of common shares outstanding and the weighted-average number of dilutive common share equivalents, comprised of shares issuable under our share-based compensation plans, during the reporting period, using the treasury stock method. The following table provides information about the diluted earnings per share calculation (in millions):
 Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Dilutive common share equivalents included in diluted shares13 12 
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period— 
v3.24.1.u1
Commitments and Contingencies
6 Months Ended
Mar. 24, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal and Regulatory Proceedings.
Consolidated Securities Class Action Lawsuit: On January 23, 2017 and January 26, 2017, securities class action complaints were filed by purported stockholders of us in the United States District Court for the Southern District of California against us and certain of our then current and former officers and directors. The complaints alleged, among other things, that we violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 thereunder, by making false and misleading statements and omissions of material fact in connection with certain allegations that we are or were engaged in anticompetitive conduct. The complaints sought unspecified damages, interest, fees and costs. The court consolidated the two actions, and on July 3, 2017, the plaintiffs filed a consolidated amended complaint asserting the same basic theories of liability and requesting the same basic relief. On May 23, 2022, the plaintiffs filed a motion for class certification, and on March 20, 2023, the court issued an order granting in part and denying in part the plaintiffs’ motion for class certification. The order denied class certification on the basis of alleged misrepresentations relating to our chip-level licensing practices, but certified a class on the basis of alleged misrepresentations relating to the separate operations of QCT and QTL. Trial is scheduled to begin on October 28, 2024. We intend to continue to vigorously defend ourselves in this matter.
Consumer Class Action Lawsuits: Beginning in January 2017, a number of consumer class action complaints were filed against us in the United States District Courts for the Southern and Northern Districts of California, each on behalf of a putative class of purchasers of cellular phones and other cellular devices. The cases filed in the Southern District of California were subsequently transferred to the Northern District of California. On July 11, 2017, the plaintiffs filed a consolidated amended complaint alleging that we violated California and federal antitrust and unfair competition laws by, among other things, refusing to license standard-essential patents to our competitors, conditioning the supply of certain of our baseband chipsets on the purchaser first agreeing to license our entire patent portfolio, entering into exclusive deals with companies, including Apple Inc., and charging unreasonably high royalties that do not comply with our commitments to standard setting organizations. The complaint sought unspecified damages and disgorgement and/or restitution, as well as an order that we be enjoined from further unlawful conduct. On September 27, 2018, the court certified the class. We appealed the court’s class certification order to the United States Court of Appeals for the Ninth Circuit (Ninth Circuit). On September 29, 2021, the Ninth Circuit vacated the class certification order, ruling that the district court had failed to correctly assess the propriety of applying California law to a nationwide class, and remanded the case to the district court. On June 10, 2022, the plaintiffs filed an amended complaint, limiting the proposed class to California residents rather than a nationwide class. We filed a motion to dismiss the amended complaint, and on January 6, 2023, the court issued an order granting in part and denying in part our motion to dismiss. We subsequently filed a motion for summary judgment on the plaintiffs’ remaining claims. The court granted our motion in its entirety and, on October 5, 2023, entered final judgment in Qualcomm’s favor. On November 2, 2023, the plaintiffs filed a notice of appeal to the Ninth Circuit. We intend to continue to vigorously defend ourselves in this matter.
Beginning in November 2017, several other consumer class action complaints were filed against us in Canada (in the Supreme Court of British Columbia and the Quebec Superior Court), Israel (in the Haifa District Court) and the United Kingdom (in the Competition Appeal Tribunal), each on behalf of a putative class of purchasers of cellular phones and other cellular devices, alleging violations of certain of those countries’ competition and consumer protection laws and seeking damages. The claims in these complaints are similar to those in the U.S. consumer class action complaints described above. These matters are at various stages of litigation, and we intend to continue to vigorously defend ourselves.
ParkerVision, Inc. v. QUALCOMM Incorporated: On May 1, 2014, ParkerVision filed a complaint against us in the United States District Court for the Middle District of Florida alleging that certain of our products infringed seven ParkerVision patents. On August 21, 2014, ParkerVision amended the complaint, alleging that we infringed 11 ParkerVision patents and sought damages and injunctive and other relief. ParkerVision subsequently reduced the number of patents asserted to three. The asserted patents are now expired, and injunctive relief is no longer available. ParkerVision continues to seek damages related to the sale of many of our radio frequency (RF) products sold between 2008 and 2018. On March 23, 2022, the court entered judgment in our favor on all claims and closed the case. On April 20, 2022, ParkerVision filed a notice of appeal to the United States Court of Appeals for the Federal Circuit, and on November 6, 2023, the court held a hearing on the appeal. The court has not yet issued a ruling. We intend to continue to vigorously defend ourselves in this matter.
Arm Ltd. v. QUALCOMM Incorporated: On August 31, 2022, Arm Ltd. (Arm) filed a complaint against us in the United States District Court for the District of Delaware. Our subsidiaries Qualcomm Technologies, Inc. and NuVia, Inc. (Nuvia) are also named in the complaint. The complaint alleges that following our acquisition of Nuvia, we and Nuvia breached Nuvia’s Architecture License Agreement with Arm (the Nuvia ALA) by failing to comply with the termination obligations under the Nuvia ALA. The complaint seeks specific performance, including that we cease all use of and destroy any technology that was developed under the Nuvia ALA, including processor core technology. Arm also contends that we violated the Lanham Act through trademark infringement and false designation of origin through unauthorized use of Arm’s trademarks and seeks associated injunctive and declaratory relief. Arm further seeks exemplary or punitive damages, costs, expenses and reasonable attorney’s fees, and equitable relief addressing any infringement occurring after entry of judgment.
On September 30, 2022, we filed our Answer and Counterclaim in response to Arm’s complaint denying Arm’s claims. Our counterclaim seeks a declaratory judgment that we did not breach the Nuvia ALA or the Technology License Agreement between Nuvia and Arm (together with the Nuvia ALA, the Arm-Nuvia Agreements) and that, following the acquisition of Nuvia, our architected cores (including all further developments, iterations or instantiations of the technology we acquired from Nuvia), server System-on-Chip (SoC) and compute SoC are fully licensed under our existing Architecture License Agreement with Arm (the Qualcomm ALA) and Technology License Agreement with Arm (together with the Qualcomm ALA, the Arm-Qualcomm Agreements). We further seek an order enjoining Arm from making any claim that our products are not licensed under the Arm-Qualcomm Agreements, are not Arm-compliant or that we are prohibited from using Arm’s marks in the marketing of any such products. On October 26, 2022, we filed an Amended Counterclaim seeking additional declaratory relief that certain statements Arm is making in the marketplace concerning our rights under the Arm-Qualcomm Agreements are false, and that Arm has no right to prevent us from shipping our products, which are validly licensed. On March 22, 2024, we filed a Second Amended Counterclaim asserting that Arm has breached the Arm-Nuvia Agreements by continuing to use Nuvia technology and by failing to return or destroy Nuvia confidential information after the Arm-Nuvia Agreements were terminated. The Second Amended Counterclaim seeks damages related to the asserted breaches. Trial is scheduled to begin on December 16, 2024. We intend to continue to vigorously defend ourselves against Arm’s claims in this matter.
On April 18, 2024, we filed a separate complaint (captioned QUALCOMM Incorporated v. Arm Ltd.) against Arm in the United States District Court for the District of Delaware. The complaint alleges that Arm has breached the Qualcomm ALA by failing to provide certain deliverables that Arm is obligated to provide. The complaint seeks an order that Arm comply with its contractual obligations, damages, and additional relief.
Contingent Losses and Other Considerations: Litigation and investigations are inherently uncertain, and we face difficulties in evaluating or estimating likely outcomes or ranges of possible loss, particularly in antitrust and trade regulation investigations. We have not recorded any accrual at March 24, 2024 for contingent losses associated with the pending matters described above based on our belief that losses, while reasonably possible, are not probable. Further, any possible amount or range of loss cannot be reasonably estimated at this time. The unfavorable resolution of one or more of these matters could have a material adverse effect on our business, results of operations, financial condition or cash flows. We are engaged in numerous other legal actions not described above (for example, our 2010 European Commission matter relating to the Icera
complaint, and other matters arising in the ordinary course of our business, including those relating to employment matters or the initiation or defense of proceedings relating to intellectual property rights) and, while there can be no assurance, we believe that the ultimate outcome of these other legal actions will not have a material adverse effect on our business, results of operations, financial condition or cash flows.
v3.24.1.u1
Segment Information
6 Months Ended
Mar. 24, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
We are organized on the basis of products and services and have three reportable segments. We conduct business primarily through our QCT semiconductor business and our QTL licensing business. QCT develops and supplies integrated circuits and system software based on 3G/4G/5G and other technologies, including RFFE (radio frequency front-end), for use in mobile devices; automotive systems for connectivity, digital cockpit and ADAS/AD; and IoT including consumer electronic devices, industrial devices, and edge networking products. QTL grants licenses or otherwise provides rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to and/or useful in the manufacture and sale of certain wireless products. Our QSI (Qualcomm Strategic Initiatives) reportable segment makes strategic investments. We also have nonreportable segments, including QGOV (Qualcomm Government Technologies) and our cloud computing processing initiative.
The table below presents revenues and earnings (loss) before income taxes (EBT) for reportable segments (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues
QCT$8,026 $7,942 $16,449 $15,834 
QTL1,318 1,290 2,778 2,814 
QSI16 13 
Reconciling items42 36 82 77 
Total$9,389 $9,275 $19,325 $18,738 
EBT
QCT$2,288 $2,107 $4,881 $4,291 
QTL933 871 2,013 1,988 
QSI96 (53)107 (61)
Reconciling items(819)(1,030)(1,541)(1,952)
Total$2,498 $1,895 $5,460 $4,266 
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues
Nonreportable segments$42 $36 $82 $77 
EBT
Unallocated cost of revenues$(57)$(47)$(113)$(112)
Unallocated research and development expenses(584)(494)(1,116)(1,018)
Unallocated selling, general and administrative expenses(229)(126)(414)(292)
Unallocated other (expenses) income (Note 2)
— (208)28 (288)
Unallocated interest expense(172)(178)(350)(348)
Unallocated investment and other income, net228 36 434 123 
Nonreportable segments(5)(13)(10)(17)
$(819)$(1,030)$(1,541)$(1,952)
v3.24.1.u1
Fair Value Measurements and Marketable Securities
6 Months Ended
Mar. 24, 2024
Fair Value Measurements [Abstract]  
Fair Value Measurements and Marketable Securities Fair Value Measurements and Marketable Securities
The following table presents our fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 24, 2024 (in millions):
Level 1Level 2Level 3Total
Assets    
Cash equivalents$6,197 $1,813 $— $8,010 
Marketable securities:    
Corporate bonds and notes— 3,844 — 3,844 
U.S. Treasury securities and government-related securities217 39 — 256 
Mortgage- and asset-backed securities— 402 — 402 
Equity securities130 — — 130 
Total marketable securities347 4,285 — 4,632 
Derivative instruments— 27 — 27 
Other investments889 — 33 922 
Total assets measured at fair value$7,433 $6,125 $33 $13,591 
Liabilities    
Derivative instruments$— $243 $— $243 
Other liabilities886 — — 886 
Total liabilities measured at fair value$886 $243 $— $1,129 
Long-term Debt. At March 24, 2024, the aggregate fair value of our outstanding fixed-rate notes, based on Level 2 inputs, was approximately $14.8 billion.
Marketable Securities. At March 24, 2024 and September 24, 2023, our marketable securities were all classified as current and were primarily comprised of available-for-sale debt securities (substantially all of which were corporate bonds and notes).
The contractual maturities of available-for-sale debt securities were as follows (in millions):
March 24,
2024
Years to Maturity
Less than one year$1,728 
One to five years2,367 
Five to ten years
No single maturity date402 
Total$4,502 
Debt securities with no single maturity date included mortgage- and asset-backed securities.
v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Pay vs Performance Disclosure        
Net income $ 2,326 $ 1,704 $ 5,093 $ 3,939
v3.24.1.u1
Insider Trading Arrangements - Alex Rogers [Member]
3 Months Ended
Mar. 24, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 7, 2024, Alex Rogers, our President, QTL and Global Affairs, adopted a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K) providing for the sale of an aggregate of (i) 13,373 shares of our common stock plus (ii) 90% of the net shares issued to Mr. Rogers upon the vesting of equity awards representing 83,280 shares of our common stock (assuming that any shares underlying performance stock units vest at target amounts), including accrued dividend-equivalent shares and excluding any shares withheld to satisfy tax withholding obligations in connection with the settlement of such equity awards. Trades under the plan are scheduled to commence in calendar 2025, and the plan is scheduled to terminate on December 31, 2026.
Name Alex Rogers
Title President, QTL and Global Affairs
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 7, 2024
Arrangement Duration 1058 days
Tranche One [Domain]  
Trading Arrangements, by Individual  
Aggregate Available 13,373
Tranche Two [Domain]  
Trading Arrangements, by Individual  
Aggregate Available 83,280
v3.24.1.u1
Basis of Presentation and Significant Accounting Policies Update (Policies)
6 Months Ended
Mar. 24, 2024
Basis of Presentation [Abstract]  
Fiscal Period, Policy We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three and six months ended March 24, 2024 and March 26, 2023 included 13 weeks and 26 weeks, respectively.
Use of Estimates, Policy The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
Recent Accounting Pronouncements, Policy
Segment Reporting Disclosures: In November 2023, the Financial Accounting Standards Board (FASB) issued new requirements to disclose certain incremental segment information on an annual and interim basis, including (among other items) additional disclosure about significant segment expenses. We will adopt the new requirements for our annual periods starting in fiscal 2025 (and interim periods thereafter) on a retrospective basis.
Income Tax Disclosures: In December 2023, the FASB issued new requirements to disclose annually certain additional detailed income tax information related to the effective tax rate reconciliation and income taxes paid, among other items. We will adopt the new requirements starting in fiscal 2026 on a retrospective basis.
Revenue Recognition, Policy We disaggregate our revenues by segment (Note 6), by products and services (as presented on our condensed consolidated statement of operations), and for our QCT (Qualcomm CDMA Technologies) segment, by revenue stream, which is based on the industry and application in which our products are sold (as presented below). In certain cases, the determination of QCT revenues by industry and application requires the use of certain assumptions. Substantially all of QCT’s revenues consist of equipment revenues that are recognized at a point in time, and substantially all of QTL’s (Qualcomm Technology Licensing) revenues represent licensing revenues that are recognized over time and are principally from royalties generated through our licensees’ sales of mobile handsets.
Earnings Per Common Share, Policy Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income by the combination of the weighted-average number of common shares outstanding and the weighted-average number of dilutive common share equivalents, comprised of shares issuable under our share-based compensation plans, during the reporting period, using the treasury stock method.
Segment Reporting, Policy We are organized on the basis of products and services and have three reportable segments.
v3.24.1.u1
Composition of Certain Financial Statement Items (Tables)
6 Months Ended
Mar. 24, 2024
Condensed Financial Information Disclosure [Abstract]  
Inventories
Inventories (in millions)
March 24,
2024
September 24,
2023
Raw materials$157 $176 
Work-in-process3,670 4,096 
Finished goods2,260 2,150 
$6,087 $6,422 
Other Current Liabilities
Other Current Liabilities (in millions)
March 24,
2024
September 24,
2023
Customer incentives and other customer-related liabilities
$2,441 $1,821 
Income taxes payable
1,093 1,717 
Other
875 953 
$4,409 $4,491 
QCT Revenues Disaggregated
QCT revenue streams were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Handsets (1)$6,180 $6,105 $12,867 $11,860 
Automotive (2)603 447 1,201 903 
IoT (internet of things) (3)
1,243 1,390 2,381 3,071 
Total QCT revenues$8,026 $7,942 $16,449 $15,834 
(1) Includes revenues from products sold for use in mobile handsets.
(2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
(3) Primarily includes products sold for use in the following industries and applications: consumer (including computing, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
Revenue recognized from performance obligations satisfied in previous periods
Revenues recognized from performance obligations satisfied (or partially satisfied) in previous periods generally include certain QCT sales-based royalty revenues related to system software, certain amounts related to QCT customer incentives and QTL royalty revenues recognized related to devices sold in prior periods (including adjustments to prior period royalty estimates, which includes the impact of the reporting by our licensees of actual royalties due) and were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues recognized from previously satisfied performance obligations$55 $170 $206 $337 
Customer Concentrations - Revenues Revenues from each customer/licensee that were 10% or greater of total revenues were as follows:
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Customer/licensee (x)
24 %25 %21 %19 %
Customer/licensee (y)
19 27 22 31 
Customer/licensee (z)14 *14 *
*Less than 10%
Investment and Other Income (Expense), Net
Investment and Other Income (Expense), Net (in millions)
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Interest and dividend income$160 $59 $312 $114 
Net (losses) gains on marketable securities
(3)20 
Net gains on other investments155 — 159 — 
Net gains on deferred compensation plan assets
62 21 126 47 
Impairment losses on other investments(50)(87)(62)(101)
Other(18)(1)(20)
$330 $(16)$542 $60 
v3.24.1.u1
Capital Stock Earnings per Common Share (Tables)
6 Months Ended
Mar. 24, 2024
Earnings Per Share [Abstract]  
Schedule of Capital Units
Shares Outstanding. Shares of common stock outstanding at March 24, 2024 were as follows (in millions):
Balance at September 24, 2023
1,114 
Issued15 
Repurchased(11)
Balance at March 24, 2024
1,118 
Schedule of Earnings Per Share, Basic and Diluted The following table provides information about the diluted earnings per share calculation (in millions):
 Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Dilutive common share equivalents included in diluted shares13 12 
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period— 
v3.24.1.u1
Segment Information (Tables)
6 Months Ended
Mar. 24, 2024
Segment Reporting [Abstract]  
Revenues and EBT for reportable segments
The table below presents revenues and earnings (loss) before income taxes (EBT) for reportable segments (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues
QCT$8,026 $7,942 $16,449 $15,834 
QTL1,318 1,290 2,778 2,814 
QSI16 13 
Reconciling items42 36 82 77 
Total$9,389 $9,275 $19,325 $18,738 
EBT
QCT$2,288 $2,107 $4,881 $4,291 
QTL933 871 2,013 1,988 
QSI96 (53)107 (61)
Reconciling items(819)(1,030)(1,541)(1,952)
Total$2,498 $1,895 $5,460 $4,266 
Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues
Nonreportable segments$42 $36 $82 $77 
EBT
Unallocated cost of revenues$(57)$(47)$(113)$(112)
Unallocated research and development expenses(584)(494)(1,116)(1,018)
Unallocated selling, general and administrative expenses(229)(126)(414)(292)
Unallocated other (expenses) income (Note 2)
— (208)28 (288)
Unallocated interest expense(172)(178)(350)(348)
Unallocated investment and other income, net228 36 434 123 
Nonreportable segments(5)(13)(10)(17)
$(819)$(1,030)$(1,541)$(1,952)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months EndedSix Months Ended
March 24,
2024
March 26,
2023
March 24,
2024
March 26,
2023
Revenues
Nonreportable segments$42 $36 $82 $77 
EBT
Unallocated cost of revenues$(57)$(47)$(113)$(112)
Unallocated research and development expenses(584)(494)(1,116)(1,018)
Unallocated selling, general and administrative expenses(229)(126)(414)(292)
Unallocated other (expenses) income (Note 2)
— (208)28 (288)
Unallocated interest expense(172)(178)(350)(348)
Unallocated investment and other income, net228 36 434 123 
Nonreportable segments(5)(13)(10)(17)
$(819)$(1,030)$(1,541)$(1,952)
v3.24.1.u1
Fair Value Measurements (Tables)
6 Months Ended
Mar. 24, 2024
Fair Value Measurements [Abstract]  
Fair value hierarchy for assets and liabilities measured at fair value on a recurring basis
The following table presents our fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 24, 2024 (in millions):
Level 1Level 2Level 3Total
Assets    
Cash equivalents$6,197 $1,813 $— $8,010 
Marketable securities:    
Corporate bonds and notes— 3,844 — 3,844 
U.S. Treasury securities and government-related securities217 39 — 256 
Mortgage- and asset-backed securities— 402 — 402 
Equity securities130 — — 130 
Total marketable securities347 4,285 — 4,632 
Derivative instruments— 27 — 27 
Other investments889 — 33 922 
Total assets measured at fair value$7,433 $6,125 $33 $13,591 
Liabilities    
Derivative instruments$— $243 $— $243 
Other liabilities886 — — 886 
Total liabilities measured at fair value$886 $243 $— $1,129 
Investments Classified by Contractual Maturity Date
The contractual maturities of available-for-sale debt securities were as follows (in millions):
March 24,
2024
Years to Maturity
Less than one year$1,728 
One to five years2,367 
Five to ten years
No single maturity date402 
Total$4,502 
v3.24.1.u1
Composition of Certain Financial Statement Items Inventories (Details) - USD ($)
$ in Millions
Mar. 24, 2024
Sep. 24, 2023
Inventory, Net [Abstract]    
Raw materials $ 157 $ 176
Work-in-process 3,670 4,096
Finished goods 2,260 2,150
Inventories $ 6,087 $ 6,422
v3.24.1.u1
Composition of Certain Financial Statement Items Other Current Liabilities (Details) - USD ($)
$ in Millions
Mar. 24, 2024
Sep. 24, 2023
Other Liabilities, Current [Abstract]    
Customer incentives and other customer-related liabilities $ 2,441 $ 1,821
Income taxes payable 1,093 1,717
Other 875 953
Other current liabilities $ 4,409 $ 4,491
v3.24.1.u1
Composition of Certain Financial Statement Items Revenues (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Revenue        
Revenues $ 9,389 $ 9,275 $ 19,325 $ 18,738
Contract with Customer, Performance Obligation Satisfied in Previous Period 55 170 206 337
Contract with Customer, Liability, Revenue Recognized     227 241
QCT        
Revenue        
Revenues 8,026 7,942 16,449 15,834
Handsets | QCT        
Revenue        
Revenues [1] 6,180 6,105 12,867 11,860
Automotive | QCT        
Revenue        
Revenues [2] 603 447 1,201 903
IoT | QCT        
Revenue        
Revenues [3] $ 1,243 $ 1,390 $ 2,381 $ 3,071
[1] Includes revenues from products sold for use in mobile handsets.
[2] Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
[3] Primarily includes products sold for use in the following industries and applications: consumer (including computing, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
v3.24.1.u1
Composition of Certain Financial Statement Items Concentrations (Details) - Sales - Customer Concentration Risk
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Customer/licensee (x)        
Concentration Risk        
Concentration Risk, Percentage 24.00% 25.00% 21.00% 19.00%
Customer/licensee (y)        
Concentration Risk        
Concentration Risk, Percentage 19.00% 27.00% 22.00% 31.00%
Customer/licensee (z)        
Concentration Risk        
Concentration Risk, Percentage 14.00%   14.00%  
v3.24.1.u1
Composition of Certain Financial Statement Items Investment and Other Income (Expense), Net (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Investment Income, Net [Abstract]        
Interest and dividend income $ 160 $ 59 $ 312 $ 114
Net (losses) gains on marketable securities (3) 9 8 20
Net gains on other investments 155 0 159 0
Net gains on deferred compensation plan assets 62 21 126 47
Impairment losses on other investments (50) (87) (62) (101)
Other 6 (18) (1) (20)
Investment and other income (expense), net $ 330 $ (16) $ 542 $ 60
v3.24.1.u1
Composition of Certain Financial Statement Items Discontinued Operations (Details)
$ in Billions
Jun. 01, 2023
USD ($)
Veoneer's Active Safety  
Discontinued Operations [Abstract]  
Disposal Group, Including Discontinued Operation, Consideration $ 1.5
v3.24.1.u1
Income Taxes (Details)
3 Months Ended 12 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Sep. 29, 2024
Income Taxes      
Effective income tax rate (benefit) 9.00% 10.00%  
Forecast      
Income Taxes      
Effective income tax rate (benefit)     7.00%
Forecast | FDII Effective Tax Rate      
Income Taxes      
Effective income tax rate (benefit)     13.00%
v3.24.1.u1
Capital Stock Share Repurchase Program (Details) - $10B stock repurchase program announced October 12, 2021 - USD ($)
$ in Billions
Mar. 24, 2024
Oct. 12, 2021
Stock Repurchase Program    
Authorized amount   $ 10.0
Remaining authorized amount $ 3.6  
v3.24.1.u1
Capital Stock Shares Outstanding (Details)
shares in Millions
6 Months Ended
Mar. 24, 2024
shares
Shares Outstanding [Abstract]  
Balance at September 24, 2023 1,114
Issued 15
Repurchased (11)
Balance at March 24, 2024 1,118
v3.24.1.u1
Capital Stock Dividends (Details) - $ / shares
3 Months Ended 6 Months Ended
Jun. 20, 2024
May 30, 2024
Apr. 17, 2024
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Mar. 05, 2024
Capital Stock Dividends                
Dividends per share announced       $ 0.80 $ 0.75 $ 1.60 $ 1.50  
Amount Of Increased Common Stock Dividends Per Share Announced               $ 0.85
Subsequent Event                
Capital Stock Dividends                
Dividends per share announced     $ 0.85          
Dividends Payable, Date Declared     Apr. 17, 2024          
Dividends Payable, Date to be Paid Jun. 20, 2024              
Dividends Payable, Date of Record   May 30, 2024            
v3.24.1.u1
Capital Stock Earnings per Common Share (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Earnings Per Share [Abstract]        
Dilutive common share equivalents included in diluted shares 13 7 12 8
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period 0 5 7 5
v3.24.1.u1
Commitments and Contingencies Legal and Regulatory Proceedings (Details)
$ in Millions
Mar. 24, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Loss Contingency, Estimate of Possible Loss $ 0
v3.24.1.u1
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 24, 2024
Mar. 26, 2023
Mar. 24, 2024
Mar. 26, 2023
Segment Reporting Information [Line Items]        
Revenues $ 9,389 $ 9,275 $ 19,325 $ 18,738
Cost of revenues (4,106) (4,153) (8,418) (8,197)
Research and development expenses (2,236) (2,210) (4,332) (4,461)
Selling, general and administrative expenses (707) (614) (1,335) (1,238)
Other Operating Income (Expense), Net 0 (208) 28 (288)
Interest expense (172) (179) (350) (348)
EBT 2,498 1,895 5,460 4,266
Reconciling Items        
Segment Reporting Information [Line Items]        
Revenues 42 36 82 77
Cost of revenues (57) (47) (113) (112)
Research and development expenses (584) (494) (1,116) (1,018)
Selling, general and administrative expenses (229) (126) (414) (292)
Other Operating Income (Expense), Net 0 (208) 28 (288)
Interest expense (172) (178) (350) (348)
Investment and other (expense) income, net 228 36 434 123
EBT (819) (1,030) (1,541) (1,952)
QCT        
Segment Reporting Information [Line Items]        
Revenues 8,026 7,942 16,449 15,834
EBT 2,288 2,107 4,881 4,291
QTL        
Segment Reporting Information [Line Items]        
Revenues 1,318 1,290 2,778 2,814
EBT 933 871 2,013 1,988
QSI        
Segment Reporting Information [Line Items]        
Revenues 3 7 16 13
EBT 96 (53) 107 (61)
Other Segments        
Segment Reporting Information [Line Items]        
Revenues 42 36 82 77
Other Segments | Reconciling Items        
Segment Reporting Information [Line Items]        
EBT $ (5) $ (13) $ (10) $ (17)
v3.24.1.u1
Fair Value Measurements Fair Value Hierarchy (Details) - Fair Value, Recurring
$ in Millions
Mar. 24, 2024
USD ($)
Assets  
Cash equivalents $ 8,010
Marketable securities 4,632
Derivative instruments 27
Other investments 922
Total assets measured at fair value 13,591
Liabilities  
Derivative instruments 243
Other liabilities 886
Total liabilities measured at fair value 1,129
Level 1  
Assets  
Cash equivalents 6,197
Marketable securities 347
Derivative instruments 0
Other investments 889
Total assets measured at fair value 7,433
Liabilities  
Derivative instruments 0
Other liabilities 886
Total liabilities measured at fair value 886
Level 2  
Assets  
Cash equivalents 1,813
Marketable securities 4,285
Derivative instruments 27
Other investments 0
Total assets measured at fair value 6,125
Liabilities  
Derivative instruments 243
Other liabilities 0
Total liabilities measured at fair value 243
Level 3  
Assets  
Cash equivalents 0
Marketable securities 0
Derivative instruments 0
Other investments 33
Total assets measured at fair value 33
Liabilities  
Derivative instruments 0
Other liabilities 0
Total liabilities measured at fair value 0
Corporate bonds and notes  
Assets  
Marketable securities 3,844
Corporate bonds and notes | Level 1  
Assets  
Marketable securities 0
Corporate bonds and notes | Level 2  
Assets  
Marketable securities 3,844
Corporate bonds and notes | Level 3  
Assets  
Marketable securities 0
U.S. Treasury and government-related Securities  
Assets  
Marketable securities 256
U.S. Treasury and government-related Securities | Level 1  
Assets  
Marketable securities 217
U.S. Treasury and government-related Securities | Level 2  
Assets  
Marketable securities 39
U.S. Treasury and government-related Securities | Level 3  
Assets  
Marketable securities 0
Mortgage- and asset-backed securities  
Assets  
Marketable securities 402
Mortgage- and asset-backed securities | Level 1  
Assets  
Marketable securities 0
Mortgage- and asset-backed securities | Level 2  
Assets  
Marketable securities 402
Mortgage- and asset-backed securities | Level 3  
Assets  
Marketable securities 0
Equity securities  
Assets  
Marketable securities 130
Equity securities | Level 1  
Assets  
Marketable securities 130
Equity securities | Level 2  
Assets  
Marketable securities 0
Equity securities | Level 3  
Assets  
Marketable securities $ 0
v3.24.1.u1
Fair Value Measurements Long-term Debt (Details)
$ in Billions
Mar. 24, 2024
USD ($)
Level 2  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Long-term Debt, Fair Value $ 14.8
v3.24.1.u1
Marketable Securities (Details) - Available-for-Sale Securities [Member]
$ in Millions
Mar. 24, 2024
USD ($)
Marketable Securities  
Less than one year $ 1,728
One to five years 2,367
Five to ten years 5
No single maturity date 402
Debt Securities, Available-for-sale $ 4,502